168 related articles for article (PubMed ID: 30066881)
1. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
[TBL] [Abstract][Full Text] [Related]
2. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
[TBL] [Abstract][Full Text] [Related]
3. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
4. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
[TBL] [Abstract][Full Text] [Related]
5. Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
Lu Y; Xu Q; Zuo Y; Liu L; Liu S; Chen L; Wang K; Lei Y; Zhao X; Li Y
BMC Cancer; 2017 Dec; 17(1):875. PubMed ID: 29262812
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival.
Xi HQ; Wu XS; Wei B; Chen L
J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22350700
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
8. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
9. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
Zhou J; Wu A; Yu X; Zhu J; Dai H
Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
[TBL] [Abstract][Full Text] [Related]
10. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
[TBL] [Abstract][Full Text] [Related]
14. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3).
Zhang S; Zhang R; Xu R; Shang J; He H; Yang Q
Gene; 2020 Apr; 733():144383. PubMed ID: 31972307
[TBL] [Abstract][Full Text] [Related]
16. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
[TBL] [Abstract][Full Text] [Related]
17. microRNA-1228
Jia L; Chen J; Xie C; Shao L; Xu Z; Zhang L
Life Sci; 2017 Jul; 180():9-16. PubMed ID: 28465246
[TBL] [Abstract][Full Text] [Related]
18. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
Liang W; Xia B; He C; Zhai G; Li M; Zhou J
Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
[TBL] [Abstract][Full Text] [Related]
20. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]